[Homocysteinemia--its significance in gynecology and obstetrics].
OBJECTIVE
Metabolic study on plasmatic levels of homocysteine (Hcy) in healthy women during normal or pathological pregnancy accompanied with corresponding levels of Hcy in amniotic fluid and foetal sera. Increased levels of Hcy--hyperhomocysteinaemia is respected as an independent risk factor accelerating the early development of vessel damage and causing the neural tube defects (NTD).


METHODS
Basic study to get our own data about Hcy in Czech healthy and population at risk of pregnant and non-pregnant women.


METHODS
Department of Obstetrics and Gynaecology, 1st Faculty of Medicine, Charles University, Prague.


METHODS
Total homocysteine in plasma, amniotic fluid and foetal sera was estimated by chromatographic method with use of fluorescence detection.


RESULTS
Normal homocysteine in preclimacteric healthy nonpregnant women is: 9.7 +/- 1.6 mumol/l with evident age-dependence. In healthy climacteric women are higher levels of Hcy (corresponding to the men values): 11.8 +/- 2.6 mumol/l. After use of hormonal contraceptives the plasmatic levels of Hcy decrease: 7.2 +/- 2.0 mumol/l. In physiological pregnancies Hcy reachs the lowest values: 4.4 +/- 1.7 mumol/l with any evident oscillations during pregnancy. In women in childbed period was Hcy 8.4 +/- 2.1 mumol/l observed. In pathological pregnanciesare its levels slightly elevated: 6.3 +/- 2.1 mumol/l, most evident in placental abruptions: 7.5 +/- 1.7 mumol/l. In pregnant women with susp. results of screening on M. Down only unsignificant increase of Hcy was observed: 6.12 +/- 2.4 mumol/l. In amnial fluids of healthy pregnant women are levels of Hcy are quite low: 4.1 +/- 1.2 mumol/l with any oscillations during pregnancy. In foetal sera of pregnancies at risk (NTD, susp., trisomy, inborn errors of metabolism): 3.6 +/- 1.4 mumol/l of Hcy was detected. The foetoplacental quotient for Hcy is 0.62.


CONCLUSIONS
Average values for Hcy were established in physiological as well as in pathological pregnancies and till now only limited diagnostic significance has been observed. The hyperhomocysteinaemia mentioned in previous papers was not in NTD observed because our pregnant patients were regularly supplemented with all critical vitamins (folate, B6, B12).
Hyánek
J
J
Oddĕlení klinické biochemie, hematologie a imunologie, Nemocnice Na Homolce, Praha.
Zivný
J
J
Dolezal
A
A
Calda
P
P
Krofta
L
L
Vinglerová
H
H
Jenícek
J
J
Dvoráková
J
J
Bocanová
E
E
Dudková
V
V
Dubská
L
L
Pejznochová
H
H
Loucka
M
M
Martiníková
V
V
Machácková
L
L
Cabrnochová
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002979:Climacteric / Q000097:blood; D000013:Congenital Abnormalities / Q000097:blood; D005260:Female; D006710:Homocysteine / Q000032:analysis / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D049590:Postpartum Period / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D012307:Risk Factors
D006710:Homocysteine